A. C. S. A. Herrera

740 total citations
14 papers, 525 citations indexed

About

A. C. S. A. Herrera is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, A. C. S. A. Herrera has authored 14 papers receiving a total of 525 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Genetics. Recurrent topics in A. C. S. A. Herrera's work include Estrogen and related hormone effects (5 papers), Chemotherapy-induced cardiotoxicity and mitigation (4 papers) and Antioxidant Activity and Oxidative Stress (3 papers). A. C. S. A. Herrera is often cited by papers focused on Estrogen and related hormone effects (5 papers), Chemotherapy-induced cardiotoxicity and mitigation (4 papers) and Antioxidant Activity and Oxidative Stress (3 papers). A. C. S. A. Herrera collaborates with scholars based in Brazil and India. A. C. S. A. Herrera's co-authors include Carolina Panis, Rúbens Cecchini, Vanessa Jacob Victorino, Alessandra Lourenço Cecchini, F. C. Campos, Andréa Name Colado Simão, Lucas Freitas de Freitas, Tatiane De Rossi, Phileno Pinge‐Filho and Décio Sabbatini Barbosa and has published in prestigious journals such as Breast Cancer Research and Treatment, Oxidative Medicine and Cellular Longevity and Molecular and Cellular Endocrinology.

In The Last Decade

A. C. S. A. Herrera

14 papers receiving 516 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. C. S. A. Herrera Brazil 12 207 154 108 76 62 14 525
F. C. Campos Brazil 8 187 0.9× 133 0.9× 78 0.7× 69 0.9× 50 0.8× 11 480
Ebru Alp Türkiye 16 276 1.3× 95 0.6× 169 1.6× 48 0.6× 91 1.5× 35 626
Thorsten J. Maier Germany 14 247 1.2× 124 0.8× 72 0.7× 65 0.9× 57 0.9× 24 670
Valérie Chopin France 13 462 2.2× 190 1.2× 118 1.1× 51 0.7× 31 0.5× 16 708
Yuko Nagayasu Japan 18 449 2.2× 82 0.5× 98 0.9× 35 0.5× 52 0.8× 32 718
C.-W. Chi Taiwan 17 240 1.2× 83 0.5× 108 1.0× 42 0.6× 52 0.8× 31 705
Bong Jun Cho South Korea 14 324 1.6× 112 0.7× 106 1.0× 29 0.4× 36 0.6× 19 610
Jayraz Luchoomun United States 13 280 1.4× 99 0.6× 132 1.2× 28 0.4× 74 1.2× 17 764
Tura C. Camilli United States 11 464 2.2× 118 0.8× 98 0.9× 76 1.0× 60 1.0× 13 721

Countries citing papers authored by A. C. S. A. Herrera

Since Specialization
Citations

This map shows the geographic impact of A. C. S. A. Herrera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. C. S. A. Herrera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. C. S. A. Herrera more than expected).

Fields of papers citing papers by A. C. S. A. Herrera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. C. S. A. Herrera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. C. S. A. Herrera. The network helps show where A. C. S. A. Herrera may publish in the future.

Co-authorship network of co-authors of A. C. S. A. Herrera

This figure shows the co-authorship network connecting the top 25 collaborators of A. C. S. A. Herrera. A scholar is included among the top collaborators of A. C. S. A. Herrera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. C. S. A. Herrera. A. C. S. A. Herrera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Victorino, Vanessa Jacob, et al.. (2021). Proinflammatory circulating markers: new players for evaluating asymptomatic acute cardiovascular toxicity in breast cancer treatment. Journal of Chemotherapy. 33(2). 106–115. 5 indexed citations
2.
Pires, Bruno Ricardo Barreto, Carolina Panis, A. C. S. A. Herrera, et al.. (2019). Label-Free Proteomics Revealed Oxidative Stress and Inflammation as Factors That Enhance Chemoresistance in Luminal Breast Cancer. Oxidative Medicine and Cellular Longevity. 2019. 1–15. 19 indexed citations
3.
Panis, Carolina, Renata Binato, Stephany Corrêa, et al.. (2017). Short infusion of paclitaxel imbalances plasmatic lipid metabolism and correlates with cardiac markers of acute damage in patients with breast cancer. Cancer Chemotherapy and Pharmacology. 80(3). 469–478. 18 indexed citations
4.
Victorino, Vanessa Jacob, Wermerson Assunção Barroso, Isabela C. Jeremias, et al.. (2015). PGC-1β regulates HER2-overexpressing breast cancer cells proliferation by metabolic and redox pathways. Tumor Biology. 37(5). 6035–6044. 12 indexed citations
5.
Panis, Carolina, Vanessa Jacob Victorino, A. C. S. A. Herrera, et al.. (2015). Can Breast Tumors Affect the Oxidative Status of the Surrounding Environment? A Comparative Analysis among Cancerous Breast, Mammary Adjacent Tissue, and Plasma. Oxidative Medicine and Cellular Longevity. 2016(1). 6429812–6429812. 14 indexed citations
6.
Victorino, Vanessa Jacob, A. C. S. A. Herrera, Alessandra Lourenço Cecchini, et al.. (2015). Trastuzumab-based chemotherapy modulates systemic redox homeostasis in women with HER2-positive breast cancer. International Immunopharmacology. 27(1). 8–14. 18 indexed citations
7.
Herrera, A. C. S. A., Vanessa Jacob Victorino, F. C. Campos, et al.. (2014). Impact of Tumor Removal on the Systemic Oxidative Profile of Patients With Breast Cancer Discloses Lipid Peroxidation at Diagnosis as a Putative Marker of Disease Recurrence. Clinical Breast Cancer. 14(6). 451–459. 26 indexed citations
8.
Victorino, Vanessa Jacob, F. C. Campos, A. C. S. A. Herrera, et al.. (2013). Overexpression of HER-2/neu protein attenuates the oxidative systemic profile in women diagnosed with breast cancer. Tumor Biology. 35(4). 3025–3034. 26 indexed citations
9.
Panis, Carolina, A. C. S. A. Herrera, Vanessa Jacob Victorino, et al.. (2013). Clinical insights from adiponectin analysis in breast cancer patients reveal its anti-inflammatory properties in non-obese women. Molecular and Cellular Endocrinology. 382(1). 190–196. 10 indexed citations
10.
Herrera, A. C. S. A., Carolina Panis, Vanessa Jacob Victorino, et al.. (2012). Molecular subtype is determinant on inflammatory status and immunological profile from invasive breast cancer patients. Cancer Immunology Immunotherapy. 61(11). 2193–2201. 51 indexed citations
11.
Victorino, Vanessa Jacob, Carolina Panis, F. C. Campos, et al.. (2012). Decreased oxidant profile and increased antioxidant capacity in naturally postmenopausal women. AGE. 35(4). 1411–1421. 60 indexed citations
12.
Panis, Carolina, A. C. S. A. Herrera, Vanessa Jacob Victorino, et al.. (2011). Oxidative stress and hematological profiles of advanced breast cancer patients subjected to paclitaxel or doxorubicin chemotherapy. Breast Cancer Research and Treatment. 133(1). 89–97. 138 indexed citations
13.
Panis, Carolina, Vanessa Jacob Victorino, A. C. S. A. Herrera, et al.. (2011). Differential oxidative status and immune characterization of the early and advanced stages of human breast cancer. Breast Cancer Research and Treatment. 133(3). 881–888. 94 indexed citations
14.
Panis, Carolina, Vanessa Jacob Victorino, A. C. S. A. Herrera, et al.. (2011). Immunological effects of Taxol and Adryamicin in breast cancer patients. Cancer Immunology Immunotherapy. 61(4). 481–488. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026